#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Vitamin B12 deficiency Behcet's syndrome Angiosarcoma metastatic Langerhans cell sarcoma Autoimmune demyelinating disease B-cell lymphoma recurrent Tuberous sclerosis complex Biliary cancer metastatic Pancreatic carcinoma metastatic SAPHO syndrome Hypergammaglobulinaemia benign monoclonal Atypical haemolytic uraemic syndrome Muscular dystrophy Herpes simplex Ewing's sarcoma metastatic More trials…

    Learn about Rare Diseases

    Methylmalonic acidaemia – Trials in Disease Lymphangiosarcoma – Treatment Netherton’s syndrome Optic glioma – Treatment Hereditary angioedema with C1 esterase inhibitor deficiency – Treatment Leiomyosarcoma – Diagnostics Erdheim-Chester disease – Diagnostics Atypical teratoid/rhabdoid tumour of CNS – Life with Disease Ornithine transcarbamoylase deficiency – Diagnostics Hereditary motor and sensory neuropathy – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Clarithromycin Dutasteride Obeticholic Acid Volrustomig Misoprostol Zilucoplan Sodium ZINC GLUCONATE Silibinin Sot102 Mps-214 Blu-222 Citalopram Hydrochloride Sodium Phosphate Dodecahydrate Eltrombopag Soya-Bean Oil Refined Keto-Isoleucine Calcium S227928 [18F]Alf-Nota-Octreotide Perampanel Midazolam Hydrochloride More therapies…

    Learn about Your Condition

    Procedural haemorrhage Craniopharyngioma Diabetic retinal oedema Plasma cell myeloma Rhabdomyosarcoma Prostatitis Escherichia coli Kawasaki's disease Meningococcal infection Dupuytren's contracture Metabolic syndrome Lichen sclerosus Vertebrobasilar stroke Myxofibrosarcoma Procedural anxiety Lyme disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Breast cancer

  • Study of Camizestrant plus Ribociclib as First‑Line Treatment for Patients with ER‑Positive, HER2‑Negative Advanced Breast Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Camizestrant
    • Ribociclib
    France Germany Italy Poland Spain

  • Premedication with dexamethasone to prevent interstitial lung disease in breast cancer patients receiving trastuzumab deruxtecan

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Dexamethasone
    Italy

  • Evaluation of Cefazolin versus Placebo for Preventing Surgical Site Infection in Breast Cancer Lumpectomy Patients

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Sodium Hydrogen Carbonate Pheur
    • Cefazolin Sodium
    • Sodium Chloride Ph. Eur.
    France

  • Radium-223 dichloride (223RaCl) with drug combination for patients with symptomatic bone metastases from breast cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Anastrozole
    • Exemestane
    • Letrozole
    Italy

  • Prifetrastat (PF-07248144) Plus Fulvestrant in Adults With Advanced HR+/HER2- Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitor Treatment

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    • Breast cancer
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • 2-METHOXY-N-{4-METHOXY-6-[(1H-PYRAZOL-1-YL)METHYL]-1,2-BENZOXAZOL-3-YL}BENZENE-1-SULFONAMIDE
    • Fulvestrant
    France

  • A study to evaluate if silymarin prevents liver damage caused by ribociclib in patients with hormone receptor positive, HER2-negative breast cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • SILYMARIN
    • Ribociclib
    Italy
Previous Page
1 … 11 12 13 14 15 … 28
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!